The nationwide survey was undertaken in 2012 and 2013 by the Agency for Healthcare Research and Quality. It used a well-validated scale to determine depressed mood, and the researchers defined treatment as having visited a psychotherapist or other mental health professional or taken a psychiatric drug. The study is in JAMA Internal Medicine.
About 8.4 per cent of the people interviewed had depression. But of those, only 28.7 per cent had received any treatment. At the same time, of those who were treated for depression, only 29.9 per cent had screened positive for the disorder. Many people with less serious psychological problems were being treated with antidepressants and other psychiatric medicines. "There are challenges in aligning depression care with patient needs," said the lead author, Mark Olfson, a professor of psychiatry at Columbia University Medical Centre.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
